Insulin Aspart Protamine and Insulin Aspart (Vials) and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Insulin Aspart Protamine and Insulin Aspart (Vials) and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart Protamine and Insulin Aspart (Vials)-Rituximab Intravenous
- Insulin Aspart Protamine and Insulin Aspart (Vials)-Riva-Amoxicillin
- Insulin Aspart Protamine and Insulin Aspart (Vials)-Rivaroxaban
- Insulin Aspart Protamine and Insulin Aspart (Vials)-Rivastigmine
- Insulin Aspart Protamine and Insulin Aspart (Vials)-Rivastigmine Capsules
- Insulin Aspart Protamine and Insulin Aspart (Vials)-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Aspart Protamine Injection
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin aspart, recombinant Subcutaneous
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin degludec
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Degludec (U-100) Prefilled Pens
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Degludec (U-100) Vials
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Degludec (U-200) Prefilled Pens